BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8818711)

  • 1. Metabolites and DNA-binding of carbamazepine and oxcarbazepine in vitro by rat liver microsomes.
    Castrén K; Pienimäki P; Arvela P; Vähäkangas K
    Hum Exp Toxicol; 1996 Jul; 15(7):577-82. PubMed ID: 8818711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsomal metabolism of carbamazepine and oxcarbazepine in liver and placenta.
    Myllynen P; Pienimäki P; Raunio H; Vähäkangas K
    Hum Exp Toxicol; 1998 Dec; 17(12):668-76. PubMed ID: 9988371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta.
    Pienimäki P; Lampela E; Hakkola J; Arvela P; Raunio H; Vähäkangas K
    Epilepsia; 1997 Mar; 38(3):309-16. PubMed ID: 9070593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human in vitro glutathionyl and protein adducts of carbamazepine-10,11-epoxide, a stable and pharmacologically active metabolite of carbamazepine.
    Bu HZ; Kang P; Deese AJ; Zhao P; Pool WF
    Drug Metab Dispos; 2005 Dec; 33(12):1920-4. PubMed ID: 16204461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of carbamazepine and its epoxide metabolite in human and rat liver in vitro.
    Tybring G; von Bahr C; Bertilsson L; Collste H; Glaumann H; Solbrand M
    Drug Metab Dispos; 1981; 9(6):561-4. PubMed ID: 6120817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-reactive metabolites of carbamazepine in mouse liver microsomes.
    Lillibridge JH; Amore BM; Slattery JT; Kalhorn TF; Nelson SD; Finnell RH; Bennett GD
    Drug Metab Dispos; 1996 May; 24(5):509-14. PubMed ID: 8723729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro.
    Pirmohamed M; Kitteringham NR; Guenthner TM; Breckenridge AM; Park BK
    Biochem Pharmacol; 1992 Apr; 43(8):1675-82. PubMed ID: 1575766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity assessment of carbamazepine-10,11-epoxide, oxcarbazepine, and 10-hydroxy-carbazepine in two automated carbamazepine immunoassays: PETINIA and EMIT 2000.
    Parant F; Bossu H; Gagnieu MC; Lardet G; Moulsma M
    Ther Drug Monit; 2003 Feb; 25(1):41-5. PubMed ID: 12548143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat.
    Panesar SK; Bandiera SM; Abbott FS
    Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first-line antiepileptic drug carbamazepine: Reaction with biologically relevant free radicals.
    Martins IL; Nunes J; Charneira C; Morello J; Pereira SA; Telo JP; Marques MM; Antunes AMM
    Free Radic Biol Med; 2018 Dec; 129():559-568. PubMed ID: 30342189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine 10,11-epoxidation in human liver microsomes: influence of the
    Miyata-Nozaka Y; Zain SM; Taguchi M; Shigeyama M; Isobe T; Hanioka N
    Pharmazie; 2017 Dec; 72(12):747-750. PubMed ID: 29441960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of primary and sequential bioactivation pathways of carbamazepine in human liver microsomes using liquid chromatography/tandem mass spectrometry.
    Bu HZ; Zhao P; Dalvie DK; Pool WF
    Rapid Commun Mass Spectrom; 2007; 21(20):3317-22. PubMed ID: 17879390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxcarbazepine: clinical development program.
    Schwabe S
    Epilepsia; 1994; 35 Suppl 5():S51-3. PubMed ID: 8039472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplacental passage of oxcarbazepine and its metabolites in vivo.
    Myllynen P; Pienimäki P; Jouppila P; Vähäkangas K
    Epilepsia; 2001 Nov; 42(11):1482-5. PubMed ID: 11879354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-glucuronidation of carbamazepine in human tissues is mediated by UGT2B7.
    Staines AG; Coughtrie MW; Burchell B
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1131-7. PubMed ID: 15292462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of carbonyl reducing enzymes in oxcarbazepine in vitro metabolism in man.
    Malátková P; Havlíková L; Wsól V
    Chem Biol Interact; 2014 Sep; 220():241-7. PubMed ID: 25063510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effect of fluoxetine on the formation of carbamazepine epoxide.
    Gidal BE; Anderson GD; Seaton TL; Miyoshi HR; Wilenksy AJ
    Ther Drug Monit; 1993 Oct; 15(5):405-9. PubMed ID: 8249047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergy to carbamazepine: parallel in vivo and in vitro detection.
    Troost RJ; Van Parys JA; Hooijkaas H; van Joost T; Benner R; Prens EP
    Epilepsia; 1996 Nov; 37(11):1093-9. PubMed ID: 8917060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactive skin eruption with both carbamazepine and oxcarbazepine.
    Beran RG
    Epilepsia; 1993; 34(1):163-5. PubMed ID: 8422852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on metabolism of 6-chloro butyl phthalide by rat liver microsomes].
    Peng SH; Cui YY; Zhou TH
    Yao Xue Xue Bao; 1996; 31(6):466-71. PubMed ID: 9275725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.